Skip to main content

Table 4 The relationship between ITGA9/LAMB1 expression and clinical parameters of patients with MM

From: Identification of key biomarkers associated with cell adhesion in multiple myeloma by integrated bioinformatics analysis

CharacterLow ITGA9 groupHigh ITGA9 groupP-valueLow LAMB1 groupHigh LAMB1 groupP-value
Gender (M/F)120/86137/740.097125/83132/770.294
Age57.90 ± 0.6659.37 ± 0.570.17358.57 ± 0.6358.71 ± 0.610.913
ISS  0.641  0.219
I8781 7791 
II6372 6768 
III6259 6853 
R-ISS  0.896  0.001
I4340 3053 
II132138 141129 
III3333 3828 
LDH (mean, IU/l) (± SD)169.46 ± 6.68156.59 ± 3.240.628164.98 ± 5.07160.92 ± 5.380.290
β2m (mean, mg/L) (± SD)5.220.354.92 ± 0.290.9665.36 ± 0.344.78 ± 0.300.024
BM malignant PCs (mean,  %) (± SD)16.53 ± 1.1513.85 ± 1.180.00115.89 ± 1.2614.48 ± 1.060.824
GEP (Standard/High)180/33193/200.039182/31191/220.120
  1. LDH lactate dehydrogenase, β2-MG β2-microglobulin, SD standard deviation
  2. Bold values indicate the statistical significant P-value